A prospective overview of the essential requirements in molecular modeling for nanomedicine design

Future Medicinal Chemistry

Volumn 5, Issue 8, 2013, Pages 929-946

  Kumar, Pradeep ^a   Khan, Riaz A ^b   Choonara, Yahya E ^a   Pillay, Viness ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b MANAV RACHNA INTERNATIONAL INSTITUTE OF RESEARCH AND STUDIES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B LIPID COMPLEX; APREPITANT; ASPARAGINASE MACROGOL; BIOMATERIAL; CARBON NANOTUBE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; ESTRADIOL; FENOFIBRATE; FERUCARBOTRAN; FERUMOXSIL; GLATIRAMER; HEPATITIS A VACCINE; INFLUENZA VACCINE; MEGESTROL ACETATE; PACLITAXEL; PEGADEMASE; PEGAPTANIB; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; PEGVISOMANT; RAPAMYCIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SEVELAMER; SUPERPARAMAGNETIC IRON OXIDE; VERTEPORFIN;

BIOENGINEERING; BIOINFORMATICS; CLINICAL CHEMISTRY; COMPUTER PROGRAM; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG PROTEIN BINDING; DRUG TRANSPORT; HIGH THROUGHPUT SCREENING; HUMAN; MOLECULAR MODEL; NANOCHEMISTRY; NANOMEDICINE; NONHUMAN; OXYGEN SUPPLY; PACEMAKER; PHARMACOPHORE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REVIEW;

DRUG CARRIERS; DRUG DESIGN; MODELS, MOLECULAR; NANOMEDICINE; NANOPARTICLES; NANOTECHNOLOGY; SOFTWARE;

EID: 84878294795     PISSN: 17568919     EISSN: 17568927     Source Type: Journal    
DOI: 10.4155/fmc.13.67     Document Type: Review

References (123)

1. Guinand F, Pign Y. Problem solving and complex systems. In: Emergent Properties in Natural and Artificial Dynamical Systems. Aziz-Alaoui M, Bertelle C (Eds). Springer- Verlag, Berlin, Germany, 53-86 (2006).
2. Trojanek J, Croul S, Ho T et al. T-antigen of the human polyomavirus JC attenuates faithful DNA repair by forcing nuclear interaction between IRS-1 and Rad51. J. Cell. Physiol. 206(1), 35-46 (2006).
3. Biggs MJP, Richards RG, Dalby MJ. Nanotopographical modification: a regulator of cellular function through focal adhesions. Nanomedicine 6(5), 619-633 (2010).
4. Kabanov AV, Gendelman HE. Nanomedicine in the diagnosis and therapy of neurodegenerative disorders. Prog. Polym. Sci. 32(8-9), 1054-1082 (2007).
5. Jain KK. Nanomedicine: application of nanobiotechnology in medical practice. Med. Princ. Pract. 17, 89-101 (2008).
6. van De Waterbeemd H, Carter RE, Grassy G et al. Glossary of terms used in computational drug design (IUPAC recommendations 1997). Pure Appl. Chem. 69(5), 1137-1152 (1997).
7. Poater A, Saliner AG, Carbó-Dorca R et al. Modeling the structure-property relationships of nanoneedles: a journey toward nanomedicine. J. Comput. Chem. 30(2), 275-284 (2009).
8. Curco D, Zanuy D, Nussinov R et al. A simulation strategy for the atomistic modeling of flexible molecules covalently tethered to rigid surfaces: application to peptides. J. Comput. Chem. 32, 607-619 (2011).
9. Jiang T, Xu Y, Zhang MQ. Bayesian modeling and computation in bioinformatics research. In: Current Topics in Computational Molecular Biology. Jiang T, Xu Y, Zhang MQ (Eds). The MIT Press. Cambridge, MA, USA, 11-44 (2002).
10. Rubensson EH, Rudberg E, Salek P. Sparse matrix algebra for quantum modeling of large systems. Lecture Notes in Comput. Sci. 4699, 90-99 (2007).
11. Freitas AA. Understanding the crucial role of attribute interaction in data mining. Artif. Intell. Rev. 16(3), 177-199 (2001).
12. Rafii-Tabar H. Modelling the nano-scale phenomena in condensed matter physics via computer-based numerical simulations. Phys. Rep. 325, 239-310 (2000).
13. Muthu MS. Focus on the development of computer-aided nanomedicine design. Nanomedicine 7(10), 1471-1473 (2012).
14. Nielsen J, Keasling JD. Synergies between synthetic biology and metabolic engineering. Nat. Biotechnol. 29(8), 693-695 (2011).
15. Ugi I, Bauer J, Bley K et al. Computerassisted solution of chemical problems-the historical development and the present state of the art of a new discipline of chemistry. Angew. Chem. Int. Ed. Engl. 32, 201-221 (1993).
16. Singh AV, Vyas V, Patil R et al. Quantitative characterization of the influence of the nanoscale morphology of nanostructured surfaces on bacterial adhesion and biofilm formation. PLoS ONE 6(9), e25029 (2011).
17. Hilder TA, Gordon D, Chung SH. Computational modeling of transport in synthetic nanotubes. Nanomedicine 7(6), 702-709 (2011).
18. Riehemann K, Schneider SW, Luger TA et al. Nanomedicine - challenge and perspectives. Angew. Chem. Int. Ed. Engl. 48, 872-897 (2009).
19. Stephen R. Wilson Nanomedicine: Fullerene and carbon nanotube biology. In: Perspectives of Fullerene Nanotechnology. Osawa E (Ed.). Springer, NY, USA, 155-163 (2002).
20. Ghosh K, Kanapathipillai M, Korin N. Polymeric nanomaterials for islet targeting and immunotherapeutic delivery. Nano Lett. 12(1) 203-208 (2012).
21. Laurencin CT, Kumbar SG, Nukavarapu SP. Nanotechnology and orthopedics: a personal perspective. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1(1), 6-10 (2009).
22. Colombo G, Soto P, Gazit E. Peptide selfassembly at the nanoscale: a challenging target for computational and experimental biotechnology. Trends Biotechnol. 25(5), 211-218 (2007).
23. de Jong H. Modeling and simulation of genetic regulatory systems: a literature review. J. Comput. Biol. 9(1), 67-103 (2002).
24. Maojo V, García-Remesal M, de la Iglesia D. Nanoinformatics: developing advanced informatics applications for nanomedicine. In: Intracellular Delivery: Fundamental Biomedical Technologies (Volume 5). Prokop A (Ed.). Springer, NY, USA, 847-860 (2011).
25. Wagner V, Dullaart A, Bock AK, Zweck A. The emerging nanomedicine landscape. Nat. Biotechnol. 24, 1211-1217 (2006).
26. Cai W, Gao T, Hong H, Sun J. Applications of gold nanoparticles in cancer nanotechnology. Nanotechnol. Sci. Appl. 1, 17-32 (2008).
27. Allen TM, Cullis PR. Drug delivery systems: entering the mainstream. Science 303, 1818-1822 (2004).
28. Hasirci N. Micro and nano systems in biomedicine and drug delivery. In: Nanomaterials and Nanosystems for Biomedical Applications. Mozafari MR (Ed.). Springer, Dordrecht, The Netherlands, 1-26 (2007).
29. Daum N, Tscheka C, Neumeyer A et al. Novel approaches for drug delivery systems in nanomedicine: effects of particle design and shape. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 4(1), 52-65 (2012).
30. Morrison DWG, Dokmeci MR, Demirci U et al. Clinical applications of micro- and nanoscale biosensors. In: Biomedical Nanostructures. Gonsalves KE, Laurencin C, Halberstadt CR, Nair LS (Eds). John Wiley and Sons, Inc., NJ, USA, 433-454 (2008).
31. Cash KJ, Clark HA. Nanosensors and nanomaterials for monitoring glucose in diabetes. Trends Mol. Med. 16(12), 584-593 (2010).
32. Cai W, Gao T, Hong H et al. Applications of gold nanoparticles in cancer nanotechnology. Nanotechnol. Sci. Applicat. 1, 17-32 (2008).
33. Zharov VP, Mercer KE, Galitovskaya EN et al. Photothermal nanotherapeutics and nanodiagnostics for selective killing of bacteria targeted with gold nanoparticles. Biophys. J. 90(2), 619-627 (2006).
34. Gheorghe DE, Cui L, Karmonik C et al. Gold-silver alloy nanoshells: a new candidate for nanotherapeutics and diagnostics. Nanoscale Res. Lett. 6, 554 (2011).
35. Bhushan B. Therapeutic nanodevices. In: Springer Handbook of Nanotechnology. Springer-Verlag, Berlin, Germany, 279-318 (2004).
36. Sumer B, Gao J. Theranostic nanomedicine for cancer. Nanomedicine 3(2), 137-140 (2008).
37. Nikolov ID. Nanofocusing devices development and nano-medicine. Curr. Nanosci. 1(3), 211-224 (2005).
38. Gruner G. Carbon nanotube transistors for biosensing applications. Anal. Bioanal. Chem. 384, 322-335 (2006).
39. Morrison DW, Dokmeci MR, Demirci U, Khademhosseini A. Clinical applications of micro- and nanoscale sensors. In: Biomedical Nanostructures. Gonsalves KE, Laurencin CL, Halberstadt CR, Nair LS (Eds). John Wiley and Sons, Inc., NJ, USA, 433-454 (2008).
40. Nguyen TH, Hilton JP, Lin Q. Emerging applications of aptamers to micro- and nanoscale biosensing. Microfluid. Nanofluid. 6, 347-362 (2009).
41. Kim DC, Kang DJ. Molecular recognition and specific interactions for biosensing applications. Sensors 8, 6605-6641 (2008).
42. Jokerst JV, McDevitt JT. Programmable nano-bio-chips: multifunctional clinical tools for use at the point-of-care. Nanomedicine 5(1), 143-155 (2010).
43. Musumeci C, Luzio A, Pradeep CP et al. Programmable surface architectures derived from hybrid polyoxometalate-based clusters. J. Phys. Chem. C. 115, 4446-4455 (2011).
44. Bawa R. Patents and nanomedicine. Nanomedicine 2(3), 351-374 (2007).
45. Hiratsuka Y, Kamei T, Yumoto N et al. Three approaches to assembling nano-bio-machines using molecular motors. NanoBioTechnology 2(3-4), 101-115 (2006).
46. Osada Y, Gong JP. Nano-biomachine from actin and myosin gels. Polym. Sci. Series A 51(6), 689-700 (2009).
47. Yanagida T, Ishii Y. Stochastic processes in nano-biomachines revealed by single molecule detection. Biosystems 71(1-2), 233-244 (2003).
48. Gaczynska M, Osmulski PA. AFM of biological complexes: what can we learn? Curr. Opin. Colloid Interface Sci. 13(5), 351-367 (2008).
49. Vo-Dinh T. Protein nanotechnology: the new frontier in biosciences. Methods Mol. Biol. 300, 1-13 (2005).
50. Sanbonmatsu KY, Tung C-S. High performance computing in biology: multimillion atom simulations of nanoscale systems. J. Struct. Biol. 157(3), 470-480 (2007).
51. Freitas RA. Current status of nanomedicine and medical nanorobotics. J. Comput. Theor. Nanosci. 2, 1-25 (2005).
52. Stern ST, Hall JB, Yu LL et al. Translational considerations for cancer nanomedicine. J. Control. Rel. 146(2), 164-174 (2010).
53. Alves MH, Jensen BE, Smith AA et al. Poly(vinyl alcohol) physical hydrogels: new vista on a long serving biomaterial. Macromol. Biosci. 11(10), 1293-1313 (2011).
54. Bogunia-Kubik K, Sugisaka M. From molecular biology to nanotechnology and nanomedicine. Biosystems 65(2-3), 123-138 (2002).
55. Kalantari-Nejad R, Bahrami M, Rafii-Tabar H. Computational modeling of a carbon nanotube-based DNA nanosensor. Nanotechnology 21, 445501 (2010).
56. Elliott JA. Novel approaches to multiscale modelling in materials science. Int. Mater. Rev. 56, 207-225 (2011).
57. Haddish-Berhane N, Rickus JL, Haghighi K. The role of multiscale computational approaches for rational design of conventional and nanoparticle oral drug delivery systems. Int. J. Nanomedicine 2(3), 315-331 (2007).
58. McNeil SE. Nanotechnology for the biologist. J. Leukocyt. Biol. 78(3), 585-594 (2005).
59. Jain KK. The role of nanobiotechnology in drug discovery. Drug Discov. Today 10(21), 1435-1442 (2005).
60. Vizirianakis IS, Amanatiadou EP. Pharmacogenomics and nanotechnology toward advancing personalized medicine. In: Nanomedicine and Nanobiotechnology Vol XII. Logothetidis S (Ed.). Springer-Verlag, Berlin, Heidelberg, Germany, 115-134 (2012).
61. Yacoby I, Benhar I. Targeted filamentous bacteriophages as therapeutic agents. Exp. Opin. Drug Deliv. 5(3), 321-329 (2008).
62. Shah S, Liu Y, Hu W et al. Modeling particle shape-dependent dynamics in nanomedicine. J. Nanosci. Nanotechnol. 11(2), 919-928 (2011).
63. Carr R, Comer J, Ginsberg MD et al. Atomsto- microns model for small solute transport through sticky nanochannels. Lab Chip 11(22), 3766-3773 (2011).
64. Petrenko VA. Evolution of phage display: from bioactive peptides to bioselective nanomaterials . Exp. Opin. Drug Deliv. 5(8) 825-836 (2008).
65. Sanner MF, Stolz M, Burkhard P. Visualizing nature at work from the nano to the macro scale. NanoBioTechnology 1(1), 7-21 (2005).
66. Sharma G, Rege K, Budil DE et al. Reversible pH-controlled DNA-binding peptide nanotweezers: an in silico study. Int. J. Nanomedicine 3(4), 505-521 (2008).
67. Zhou C, Yue P, Feng JJ. Dynamic simulation of capillary breakup of nematic fibers:molecular orientation and interfacial rupture. J. Comput. Theor. Nanosci. 7, 683-692 (2010).
68. Tan JJ, Cong XJ, Hu LM et al. Therapeutic strategies underpinning the development of novel techniques for the treatment of HIV infection. Drug Discov. Today 15(5-6), 186-197 (2010).
69. van der Spoel D, Hess B. GROMACS - the road ahead. Wiley Interdiscip. Rev. Comput. Mol. Sci. 1(5), 710-715 (2011).
70. Chhetri P, Lee C, Rakesh L. Molecular modeling studies of interaction between plasmid DNA (pbr322) and dendritic antioxidants. J. Cancer Sci. Ther. 3(9), 220-227 (2011).
71. Thorne BC, Hayenga HN, Humphrey JD et al. Toward a multi-scale computational model of arterial adaptation in hypertension: verification of a multi-cell agent based model. Front. Physio. 2, 20 (2011).
72. Freitas RA. Pharmacytes: an ideal vehicle for targeted drug delivery. J. Nanosci. Nanotechnol. 6(9-10), 2769-2775 (2006).
73. Hu Y, Fine DH, Tasciotti E et al. Nanodevices in diagnostics. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 3, 11-32 (2011).
74. Chan WCW. Biology of blood and marrow transplantation. Bionanotechnol. Prog. Adv. 12(1), 87-91 (2006).
75. Hepel M, Zhong CJ. Functional nanoparticles for bioanalysis, nanomedicine, and bioelectronic devices. Hepel M, Zhong CJ (Eds). ACS Symposium Series, Washington, DC, USA (2012).
76. McKnight TE, Melechko AV, Griffin GD et al. Intracellular integration of synthetic nanostructures with viable cells for controlled biochemical manipulation. Nanotechnology 14, 551-556 (2003).
77. Roco MC. Nanotechnology: convergence with modern biology and medicine. Curr. Opin. Biotechnol. 14(3), 337-346 (2003).
78. Lee H, Larson RG. Multiscale modeling of dendrimers and their interactions with bilayers and polyelectrolytes. Molecules 14, 423-438 (2009).
79. Choonara YE, Pillay V, Ndesendo VM et al. Polymeric emulsion and crosslink-mediated synthesis of super-stable nanoparticles as sustained-release anti-tuberculosis drug carriers. Colloid. Surf. B Biointerfaces 87(2), 243-254 (2011).
80. Wang Y. Micro-nano-technology applications of cad/cam/cae periodic surface modeling for computer aided nano design. Comput. Aided Design 39(3), 179-189 (2007).
81. Tahoori MB. A mapping algorithm for defecttolerance of reconfigurable nanoarchitectures. 1560150 abstract Computer- Aided Design, 668-672. Presented at: ICCAD-2005. IEEE/ACM International Conference. CA, USA, 6-10 November 2005.
82. Decuzzi P. Mathematical Design of Nanoparticles for Cancer Imaging and Therapy. Presented at: 7th Annual Targeted Nanodelivery, Cambridge Healthtech Institute, BioMEMs & Nanotech World Conference. Baltimore, MD, USA, 12-13 October 2006.
83. Heng JB, Aksimentiev A, Ho C et al. The electromechanics of DNA in a synthetic nanopore. Biophys. J. 90(3), 1098-1106 (2006).
84. Fleck NA, Deshpande VS, Ashby MF. Microarchitectured materials: past, present and future. Proc. R. Soc. A 466(2121), 2495-2516 (2010).
85. González-Nilo F, Pérez-Acle T, Guínez- Molinos S et al. Nanoinformatics: an emerging area of information technology at the intersection of bioinformatics, computational chemistry and nanobiotechnology. Biol. Res. 44(1), 43-51 (2011).
86. Maojo V, Martin-Sanchez F, Kulikowski C. Nanoinformatics and DNA-based computing: catalyzing nanomedicine. Pediat. Res. 67, 481-489 (2010).
87. Lee H, Larson RG. Multiscale modeling of dendrimers and their interactions with bilayers and polyelectrolytes. Molecules 14, 423-438 (2009).
88. Pierzchalski A, Robitzki A, Mittag A et al. Cytomics and nanobioengineering. Cytometry Part B 72B, 416-426 (2008).
89. Bassiouk M, Alvarez-Zauco E, Basiuk VA. Self-assemblies of meso-tetraphenylporphine ligand on surfaces of highly oriented pyrolytic graphite and single-walled carbon nanotubes: insights from scanning tunneling microscopy and molecular modeling. J. Nanosci. Nanotechnol. 11(6), 5457-5468 (2011).
90. Buell S, Rutledge GC, van Vliet, KJ. Predicting polymer nanofiber interactions via molecular simulations. ACS App. Mater. Interface 2, 1164-1172 (2010).
91. Helmke BP, Minerick AR. Designing a nanointerface in a microfluidic chip to probe living cells: challenges and perspectives. Proc. Natl Acad. Sci. USA 103(17), 6419-6424 (2006).
92. Khan MTH. Predictions of the ADMET properties of candidate drug molecules utilizing different QSAR/QSPR modelling approaches. Curr. Drug Metabol. 11(4), 285-295 (2010).
93. Azuma M. Software products evaluation system: quality models, metrics and processes - international standards and Japanese practice. Inform. Software Technol. 38(3), 145-154 (1996).
94. Yan Q. Translational bioinformatics and systems biology approaches for personalized medicine. In: Systems Biology in Drug Discovery and Development - Methods in Molecular Biology Vol 662. Yan Q (Ed.). Springer, NY, USA 167-178 (2010).
95. Ghoniem NM, Cho K. The emerging role of multiscale modeling in nano- and micromechanics of materials. Comput. Modeling Eng. Sci. 3(2), 147-173 (2002).
96. Wegrzyn S, Winiarczyk R, Znamirowski L. Self-replication processes in nanosystems of informatics. Int. J. Appl. Math. Comput. Sci. 13(4), 585-591 (2003).
97. Marguet P, Balagadde F, Tan C et al. Biology by design: reduction and synthesis of cellular components and behaviour. J. R. Soc. Interface. 4(15), 607-623 (2007).
98. Koide T, Pang WL, Baliga NS. The role of predictive modelling in rationally reengineering biological systems. Nat. Rev. Microbiol. 7, 297-305 (2009).
99. Sayler GS, Simpson ML, Cox CD. Emerging foundations: nano-engineering and biomicroelectronics for environmental biotechnology. Curr. Opin. Microbiol. 7(3), 267-273 (2004).
100. Li J, Cheng X, Lee JC. Structure and dynamics of the modular halves of Escherichia coli cyclic AMP receptor protein. Biochemistry 41(50), 14771-14778 (2002).
101. Astier Y, Bayley H, Howorka S. Protein components for nanodevices. Curr. Opin. Chem. Biol. 9(6), 576-584 (2005).
102. Li C, Chou T-W. A structural mechanics approach for the analysis of carbon nanotubes. Int. J. Solids Struct. 40(10), 2487-2499 (2003).
103. Nicolaidis M, Kolonis E. Computational opportunities and CAD for nanotechnologies. In: Robust Computing with Nano-scale Devices Progresses and Challenges Vol. 58. Huang C (Ed.). Springer, AK Houten, The Netherlands, 137-173 (2010).
104. Xi JZ, Ho D, Chu B et al. Lessons learned from engineering biologically active hybrid nano/micro devices. Adv. Funct. Mater. 15(8), 1233-1240 (2005).
105. Reif JH, La Bean TH, Sahu S. Design, simulation, and experimental demonstration of self-assembled DNA nanostructures and motors. In: Unconventional Programming Paradigms, International Workshop UPP. Banâtre J-P, Fradet P, Giavitto J-L, Michel O (Eds). Springer, NY, USA, 173-187 (2005).
106. Chakraborty AK, Golumbfskie AJ. Polymer adsorption-driven self-assembly of nanostructures. Ann. Rev. Phys. Chem. 52, 537-573 (2001).
107. Rojas-Chapana JA, Giersig M. Multi-walled carbon nanotubes and metallic nanoparticles and their application in biomedicine. J. Nanosci. Nanotechnol. 6(2), 316-321 (2006).
108. Sarikaya M, Tamerler C, Jen AKY et al. Molecular biomimetics- nanotechnology through biology. Nat. Mater. 2, 577-585 (2003).
109. Riboh JC, Haes AJ, McFarland AD et al. A nanoscale optical biosensor: real-time immunoassay in physiological buffer enabled by improved nanoparticle adhesion. J. Phys. Chem. B 107(8), 1772-1780 (2003).
110. Bjork RL. HIV-1: seven facets of functional molecular mimicry. Immunol. Lett. 28(2), 91-95 (1991).
111. Tseng H-R, Vignon SA, Stoddart JF. Toward chemically controlled nanoscale molecular machinery. Angew. Chem. 115(13), 1529-1533 (2003).
112. de Benedetti PG, Fanelli F. Computational quantum chemistry and adaptive ligand modeling in mechanistic QSAR. Drug Discov. Today 15(19), 859-866 (2010).
113. Atwood BK, Lopez J, Wager-Miller J et al. Expression of G protein-coupled receptors and related proteins in HEK293, AtT20, BV2, and N18 cell lines as revealed by microarray analysis. BMC Genomics 12, 14 (2011).
114. Ward JM, Gorenstein NM, Tian J et al. Constraining binding hot spots: NMR and molecular dynamics simulations provide a structural explanation for enthalpy-entropy compensation in SH2-ligand binding. J. Am. Chem. Soc. 132(32), 11058-11070 (2010).
115. Huynh L, Neale C, Pomès R, Allen C. Computational approaches to the rational design of nanoemulsions, polymeric micelles, and dendrimers for drug delivery. Nanomed. Nanotechnol. Biol. Med. 8, 20-36 (2012).
116. Jaramillo-Botero A, Abrol R, van Duin A et al. Multiscale-multiparadigm modeling and simulation of nanometer scale systems and processes for nanomedical applications. In: Nanomedicine: A Systems Engineering Approach. Zhang M, Xi N (Eds). Pan Stanford Publishing, Singapore, 245-299 (2008).
117. Grattoni A, Fine D, Zabre E et al. Gated and near-surface diffusion of charged fullerenes in nanochannels. ACS Nano 5(12), 9382-9391 (2011).
118. Amir-Aslani A, Mangematin V. The future of drug discovery and development: Shifting emphasis towards personalized medicine. Technol. Forecast. Soc. Change 77(2), 203-217 (2010).
119. Schulz G, Deyhle H, Müller B. Imaging the human body: micro- and nanostructure of human tissues. In: Nanomedicine and Nanobiotechnology. Logothetidis S (Ed.). Springer, NY, USA, 69-94 (2012).
120. Lu D, Aksimentiev A, Shih AY et al. The role of molecular modeling in bionanotechnology. Phys. Biol. 3, S40-S53 (2006).
121. Lin C, Liu Y, Yan H. Designer DNA Nanoarchitectures. Biochemistry 48(8), 1663-1674 (2009).
122. Lipshtat A, Jayaraman G, He JC et al. Design of versatile biochemical switches that respond to amplitude, duration, and spatial cues. Proc. Natl Acad. Sci. USA 107(3), 1247-1252 (2010).
123. Bewick S, Yang R, Zhang M. Complex mathematical models of biology at the nanoscale. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1(6), 650-659 (2009).